New Key Statistics Module, Z-Score and F-Score
NAS:XFOR Key Ratios
| Market Cap $ M | 416.42 |
| Enterprise Value $ M | 286.66 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.60 |
| Price/Sales | 26.29 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 15.00 |
| EPS (TTM) $ | -1.24 |
| Beneish M-Score | -2 |
| 10-y EBITDA Growth Rate % | 47.80 |
| 5-y EBITDA Growth Rate % | 58.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -3.52 |
| EV-to-EBITDA | -3.59 |
| PEG | -- |
| Shares Outstanding M | 99.15 |
| Net Margin (%) | -568.80 |
| Operating Margin % | -554.71 |
| Pre-tax Margin (%) | -568.98 |
| Quick Ratio | 11.02 |
| Current Ratio | 11.30 |
| ROA % (ttm) | -41.63 |
| ROE % (ttm) | -78.27 |
| ROIC % (ttm) | -233.70 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.92 |
XFOR Number of Guru Trades
XFOR Volume of Guru Trades
Gurus Latest Trades with NAS:XFOR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:XFOR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
X4 Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:XFOR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers